These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 23026669

  • 21. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Väänänen HK, Härkönen P.
    Mol Cell Endocrinol; 2008 Jul 16; 289(1-2):38-48. PubMed ID: 18455292
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology.
    Arnal JF, Laurell H, Fontaine C, Billon A, Calippe B, Lenfant F, Gourdy P.
    Climacteric; 2009 Jul 16; 12 Suppl 1():12-7. PubMed ID: 19811234
    [Abstract] [Full Text] [Related]

  • 27. Reflections on the discovery and significance of estrogen receptor beta.
    Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA.
    Endocr Rev; 2005 May 16; 26(3):465-78. PubMed ID: 15857973
    [Abstract] [Full Text] [Related]

  • 28. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR.
    Endocrinology; 2006 Sep 16; 147(9):4132-50. PubMed ID: 16728493
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tamoxifen elicits atheroprotection through estrogen receptor α AF-1 but does not accelerate reendothelialization.
    Fontaine C, Abot A, Billon-Galés A, Flouriot G, Bergès H, Grunenwald E, Vinel A, Valera MC, Gourdy P, Arnal JF.
    Am J Pathol; 2013 Jul 16; 183(1):304-12. PubMed ID: 23669343
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system.
    Dworatzek E, Mahmoodzadeh S.
    Pharmacol Res; 2017 May 16; 119():27-35. PubMed ID: 28119050
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Target specific virtual screening: optimization of an estrogen receptor screening platform.
    Knox AJ, Meegan MJ, Sobolev V, Frost D, Zisterer DM, Williams DC, Lloyd DG.
    J Med Chem; 2007 Nov 01; 50(22):5301-10. PubMed ID: 17918820
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nonsteroidal estrogen receptor isoform-selective biphenyls.
    Bhatnagar S, Soni A, Kaushik S, Rikhi M, Santhoshkumar TR, Jayaram B.
    Chem Biol Drug Des; 2018 Feb 01; 91(2):620-630. PubMed ID: 29052968
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.